Cerus Corporation
CERS
#7533
Rank
A$0.74 B
Marketcap
A$3.70
Share price
-2.57%
Change (1 day)
90.46%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): -A$1.7 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.21 Billion. In 2025 the company made an earning of -A$9.69 Million, an increase over its 2024 earnings that were of -A$16.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$1.7 Million-82.48%
2025 -A$9.69 Million-41.58%
2024 -A$16.58 Million-58.95%
2023 -A$40.37 Million-20.74%
2022 -A$50.93 Million-25.7%
2021 -A$68.54 Million-11.99%
2020 -A$77.88 Million-14%
2019 -A$90.56 Million21.73%
2018 -A$74.39 Million-0.65%
2017 -A$74.88 Million-10.96%
2016 -A$84.1 Million4.24%
2015 -A$80.68 Million50.99%
2014 -A$53.44 Million-10.08%
2013 -A$59.43 Million184.13%
2012 -A$20.92 Million-7.91%
2011 -A$22.71 Million
2009 -A$32.08 Million-24.69%
2008 -A$42.59 Million-25.2%
2007 -A$56.94 Million330.54%
2006 -A$13.23 Million1.49%
2005 -A$13.03 Million-61.02%
2004 -A$33.43 Million
2002 -A$82.69 Million10.02%
2001 -A$75.16 Million34.25%
2000 -A$55.99 Million61.02%
1999 -A$34.77 Million-18.81%
1998 -A$42.83 Million93.08%
1997 -A$22.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.21 B-343,088.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$18.73 M-1,331.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.21 B-14,466.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$20.81 Million 1,267.28%๐Ÿ‡บ๐Ÿ‡ธ USA